Skip to main content

Table 2 Cross-sectional associations between tau biomarkers and downstream measures of neurodegeneration and cognitive impairment

From: Head-to-head comparison between plasma p-tau217 and flortaucipir-PET in amyloid-positive patients with cognitive impairment

 

Model 1: PET only

Model 2: plasma only

Model 3: both

A. Adj. Cort. Vol

\(\beta\)

95% CI of\(\beta\)

p

\(\beta\)

95% CI of\(\beta\)

p

\(\beta\)

95% CI of\(\beta\)

p

Age

 − 0.07

[− 0.13, − 0.02]

0.008

 − 0.04

[− 0.09, 0.002]

0.063

 − 0.08

[− 0.13, − 0.02]

0.007

Sex

1.29

[0.47, 2.12]

0.002

1.08

[0.27, 1.89]

0.010

1.31

[0.49, 2.14]

0.002

FTP SUVR

 − 1.75

[− 2.99, − 0.52]

0.006

 

 − 1.46

[− 2.84, − 0.09]

0.037

p-tau217

 

 − 1.33

[− 2.62, − 0.05]

0.043

 − 0.68

[− 2.08, 0.72]

0.336

R2

0.165

0.129

0.174

AIC

354

358

355

B. MMSE

\(\beta\)

95% CI of\(\beta\)

p

\(\beta\)

95% CI of\(\beta\)

p

\(\beta\)

95% CI of\(\beta\)

p

Age

 − 0.08

[− 0.24, 0.07]

0.302

0.06

[− 0.07, 0.19]

0.358

 − 0.10

[− 0.25, 0.05]

0.205

Sex

2.68

[0.28, 5.07]

0.029

1.75

[− 0.62, 4.12]

0.145

2.86

[− 0.58, 5.14]

0.015

FTP SUVR

 − 9.61

[− 13.18, − 6.04]

 < 0.001

 

 − 7.02

[− 10.78, − 3.25]

 < 0.001

p-tau217

 

 − 9.29

[− 13.05, − 5.53]

 < 0.001

 − 6.12

[− 10.02, − 2.26]

0.002

R2

0.328

0.299

0.402

AIC

526

530

518

  1. Adjusted cortical volume models (A) include all 87 patients, while MMSE models (B) include 85 patients. Sex is dummy coded as 0 for males and 1 for females so positive estimates indicate higher volumes/MMSE scores in Females. Other variables are centered, not standardized
  2. R2, coefficient of determination (higher R2 is better); AIC, Akaike Information Criterion (lower AIC is better)